Method of producing optically-active penems or salts thereof with alkali metals

专利摘要:
Processes for the preparation of a penem derivative of formula I <IMAGE> I wherein n=0 or 1; R is a carboxy protecting group or H; R1 is hydrogen, a hydrocarbon group substituted or unsubstituted, or lower alkoxy; and R2 is hydrogen, C1-C5 alkyl, carbamoyl N-substituted by lower alkyl or unsubstituted, or an acyl group; and the pharmaceutically acceptable salts thereof. These processes allow one to prepare stereospecifically only 5R derivatives, and are characterized by R2-introduction at a very late stage in the synthesis, thereby enabling a great number of compounds of formula I to be prepared. Penem derivatives are useful antibacterial agents.
公开号:SU1389680A3
申请号:SU823522502
申请日:1982-12-06
公开日:1988-04-15
发明作者:Альпеяни Марко；Баттистини Карло；Бедески Анджело；Франчески Джованни；Фоглио Маурицио；Царини Франко
申请人:Фармиталия Карло Эрба С.П.А. (Фирма)；
IPC主号:

专利说明:

phenylphosphine at 40-60 ° C. In the resulting compound, the hydroxy protecting group is removed. The forming 3, A-disubstituted 1- (1-R, α-hydroxycarbonyl-1-triphenylphosphoranylidenemethyl) -azetidinone-2 is cyclized in toluene or xylene as the organic solvent at 80 -150 With the selection of the target product, where R is an atom of H, or it is treated with acetic anhydride at
room temperature in methylene chloride in the presence of pyridine or trichloroacetyl isocyanate in acetone and, if necessary, remove the protective group by treating with silica gel in methanol or hydrogen in ethyl acetate in the presence of 5% palladium on carbon and, if necessary, the desired product, where in the form of its alkali metal salt by treatment with a base.
one
The invention relates to an improved process for the preparation of optically active penems or their salts with alkaline metals, which have antibacterial activity, and also inhibit α-3-lactamase and can be used in medicine.
The purpose of the invention is to increase the yield and expand the range of target products.
The goal is achieved by changing the sequence of stages in a known ten-step process to produce other intermediate products in separate stages, which results in both new and known optically active penems with a higher yield.
The invention is illustrated by the following examples in which the reduction in PNB. means paranitrobenzyl, TBVR8 - t-butyldiphenylsilyl and TBDMS - t-butyldimethylsilyl.
PRI me R 1. Stadi A.
4-Acetoxy-ZN- (1R-para-nitrobenzyloxycarbonyloxyethyl) -azetidin--2-one
-N- ul)
COOCHj
SPIRMV
Day o-pine
Ns
H COOCH (V)
osogrk
L2 0-COCHN
od1
UV) H COOCHN
OC02PNB L 0-COCHN
%
Metop A.V or C
A solution of 9.1 g (0.02 mol) of methyl-6-alpha- (1R-para-nitrobenzyloxycarbonyloxyethyl) penicilanate 1-oxide (II) in 100 ml of toluene is treated with 4 ml of 5 (0.07 mol) acetic acid and.
13.4 ml of trimethylphosphite. The resulting mixture is refluxed - for 3 hours, cooled to room temperature, washed with saturated;
10 solution of sodium bicarbonate (3 times 50 ml), water (50 ml), then dried with anhydrous sodium sulfate. And evaporated in vacuo. The resulting oily residue is subjected to
5 are purified by chromatography on a column, using a mixture consisting of cyclohexane-and ethyl acetate as eluent: the result is 4-acetoxy-3R- (1R-para-0-nitrobenzyloxycarbonyloxy-ethyl) -1-1- ( 1-methoxycarbonyl-2-methyl-2-propyl) -azetidin-2-one (IV) in the form of a light yellow oil in the amount of 7.9 g (yield 85%). Isopropenyl
a fragment of this compound is subjected to isomerization by treating with triethyl amine in dichloromethane at 5 ° C to obtain as a result of 4-acetoxy-3R- (1R-para-nitro-benzyl-hydroxy-parabenyl oxy-ethyl) -1 (1-methoxy: rbonyl-2-methyl -1-propenyl) -azetidin-2-one. (V) with a yield of 92% of theoretical, which is obtained as a mixture consisting of cis- and trans-acetate, and
5 is used as the source in the methods of synthesis of A, B and C.
Method A. To a solution of 2.46 g (5.29 mmol) of the compound obtained as indicated in 200 ml of acetone.
a solution of 4.51 g (21.08 mmol sodium metaperiodate in 140 ml of water) is added. Next, a VO ml of 0.1 M phosphate buffer solution, characterized by a pH value equal to pH 7, is added, while the temperature is maintained in the range of 10 to to 15 ° C. Next, 65 mg (0.41 mmol) of potassium permanganate is added. The resulting mixture is stirred at room temperature for 5 hours, the precipitate is filtered off, the remaining filtrate is concentrated to 200 ml. The aqueous phase is then extracted with ethyl acetate. the layer is further collected, washed with brine m, dried with anhydrous sodium sulfate and concentrated in vacuo. The residue is chromatographed on silica gel, eluted with a mixture of cyclohexane and ethyl acetate. As a result, the title compound is obtained as a foam (1.48 g, 79% of theoretical output).
Method B. In accordance with this method, a 1- (1-methoxycarbonyl-2-methyl-1-propyl) -3 (R) (K) -paranitrobenzyloxycarbonyloxyethyl-4 (R, S) acetoxy- Azetidin-2-one (7.9 g 17 mmol in acetone (180 ml), water (25 ml) and 0.1 M M phosphate buffer (5 ml), characterized by a pH of 7, is added. portions at 15 to 20 ° C, permanganate, potassium in the amount of 5.37 g, 34 mmol. The mixture is stirred under nitrogen at room temperature for 40 minutes. The organic solvent is separated by evaporation in a akume
A layer of ethyl acetate on top covers the aqueous phase. The resulting mixture is stirred and treated with cold aqueous sodium thiosulfate solution in order to eliminate excess potassium permanganate.
The organic layer is washed with brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue obtained is purified by chromatography on a column of the title compound in an amount of 4.96 g of 83% of the theoretical yield.
Method C. An oxygen stream is bubbled through oxygen through a solution of 3.2 g of 4- -acetoxy-3 (K) (K) -para-nitrobenzyloxycarbonyloxyethyl -1- (1-methoxycarbonyl-2-methyl-1-propenyl) -azethidin-2-one in methylene chloride (100 ml) at the time of the appearance of a blue color.
Nitrogen was then passed through the solution for half an hour. Dimethyl sulfide (3 ml) was then added and the clear solution was heated to room temperature. The solvent and excess dimethyl sulfide are then removed by evaporation under vacuum.
The oily residue was treated with ethyl acetate (100 ml), washed with 4% aqueous sodium bicarbonate solution, brine, dried over sodium sulfate, and concentrated under reduced pressure.
The residue was dissolved in methanol (100 ml C, silica gel was added. (30 g) and the mixture was stirred for 3 h.
The silica gel is filtered off and washed thoroughly with methanol. The combined filtrates are evaporated under vacuum, the residue is purified by a column. chromatography to obtain the title compound (1.83 g, 75%).
IR spectrum. (Pure substance): 1770-1740 cm-.
PMR (CDCl1): 1.5 and 1.53 (3N, doublet, I 7 Hz); 1.98 and 2.1 (2H, singlet); 5.3 (1H, multiplet); 5.88 and 5.95 (1H, doublet), I 1.3 and 4.0 Hz)); 6.8 (1H, wide siglet); 7.57 (2H, doublet, I 8 Hz); 8.25 (2H, doublet, Hz).
Stage B. 4 (K) -T-butyldiphenylsilyloxyacetylthio-3 (8)) - para -nitrrbenzyloxycarbonyloxyethyl OC02RKB azetidin-2-one
.OCA 9 20TBDPs
oJ-NH
Cosh
OC02PNB

N-i V OTBDPS 0
The thioacid (4.24 g) is dissolved in a solution consisting of 0.56 g of sodium hydroxide in 60 ml of water, at 5 ° C. After 10 MHFf, D-acetoxy-3 (3) (K) -pair is added -nitrobenzyloxycarbonyloxyethO-azetidin-2-oia (4, g) c. The resulting reaction mixture was vigorously stirred for 1 hour, 70 ml of dilute citric acid solution was added and then the organic phase was separated.
The aqueous phase is extracted with ethyl acetate (3 times 50 ml), the sour cream organic extracts are dried with sodium sulfate, evaporated and chromatographed on silica gel, elution is carried out with a mixture of cyclohexane and ethyl acetate, to give the title compound 4.42 g (59% yield) as a white foam.
IR spectrum: -O max. 1770-1740, 1690. .
Spectrum of Poland (CDCl1): 1.13 (9H, s), 1.48 (3N, d, I 7 Hz), 3.48 (1.dd, I. 2.0, 6.5 Hz), 4, 25 (2H, s), 5.2 (1H, ha), 5.25 (2H, S), 5.31 (1H, d, Hz), 6.4 (1H, wide singlet year), 7, 5-7.7 (12H, ha), 8.22 (2H, d, I 8 Hz).
Step C. 4 (K) -T-Butyldiphenylsilyloxyacetylthio-3 (8) - 1 (R) -napa- -nitrobenzyloxycarbonyloxyethyl - - - (1-para-nitrobenzyloxycarbonyl-1-oxymethyl) azetidin-2-one
OC02PNB
0
V OTBDPS 0
OCOiPMB H s

coopTSTB
Solution of 4 (K) -tert-butyldiphenylsilyl xiacetylthio-3 (s) -C1 (R) -napa- -nitrobenzyloxycarbonyl-yloxyethyl-α-azididin-3-one (3.11 g 5 mmol) and para-nitrobenzylglyoxylate (3 , 20 g, 12.5 mmol) in benzene (100 ml) is refluxed with removal of water by azeotropic distillation to an almost dry product (5 ml). After refluxing for 2 h, the reaction
the mixture is chromatographed on silica gel using it as an eluant a mixture consisting of ethyl acetate and cyclohexane, thereby obtaining a 3.5 g epinematic mixture of carbinol amides (84% yield).
Stage D. 4 (K) -T-butyldiphenylsilyloxyacetylthio-3 (5) (R) -napa-nitrobenzyloxycarbonyloxyethyl -1- - (1-para-nitrobenzyloxycarbonyl-1- -chloromethyl) azetidin-2-one
OC02PNB
n s
 K OTBDPS
 about:.
oh it
 OC02P NB
OTBDPs l Y OTBDPS
-.
0 VGI
OCOPMB
0
five
0
five
0
five
A stirred solution of 4 (K) -t-β-butyldiphenylsilyloxyacetylthio-3- (S) (R) -para-nitrobenzyloxycarbonyloxyethyl -1- (1-para-nitrobenzyloxycarbonyl-1-hydroxymethyl) -azethydin-2-one ( 3.5 g, 4.2 mmol) in anhydrous tetrahydrofuran at 0-5 ° C are treated with pyridine (0.48 ml, 6 mmol.) And thionyl chloride (0.43 ml, 6 mmol). After 30 min, this reaction mixture filtered and the filtrate evaporated in vacuo to give the chlorine esters as a yellow resin, 3.5 g, yield 98%.
Stage E. 4-R) -tert-butyl diphenylsilyloxyacetylthio-3- (8) - l- (R) -para -nitrobenzyloxycarbonyloxyethyl-1- (1-para-nitrobenzyloxycarbonyl--1-triphenylphosphoranylidenemethyl) -azo-TIDIN -2-OH
OS02R
AJf -rt OTBDPS
. 0
ABOUT
CSTBDPS
-Y Cl СООРМВ OC02PMB
I
H-f OTBDPS, COOPNB
A solution of 4 (K) -tert-butyldiphenylsilyl-oxyacetylthio-3 (5) (K) -para-nitro-benzyloxycarbonyloxyethyl J-1- (1-para-nitrobenzyloxycarbonyl-1-chloro-methyl) -azetidine-2-one obtained As indicated above, in tetrahydrofuran is treated with (C / Hc) P (2.2 g, 8.5 mmol) and silica gel (20 g). The resulting mixture is evaporated in vacuo to a dry product and the resulting powder is left to stand for 2 hours at room temperature. This powder is then loaded into the top of the column and the phosphoran is zoned using mixtures consisting of cyclohexane and ethyl acetate, to give the title product in an amount of 3.2 g (yield 72%) as a light foam. yellow color .
.Staff F. 4 (K) -oxiacetylthio-3 (8) t1 (U-para-nitrobenzylrxycarbonyloxyethyl J-1- (1-para-nitrobenzyloxycarbonyl-1-triphenylphosphoranylidene-methyl) -azetidin-2-one
OS02RMV lu with
P V OTBDPS
J o.
otBDPS
ARRZ SOOR13V
OCOiPl B

COOPNB
0
Trifluoroacetic acid (4 ml) is added to a stirred solution of 4 (R) -tert-butyldiphenylsilyloxyacetylthio-3- (S) -t1 (R) -para-nitrobenzyloxycarbonyloxyethyl -1- (1-para -nitrobenzylskycarbonyl-1 -triphenylphosphora nilidenemethyl) -azetidin-2-one (1.07 g, 1 mmol) in ethyl acetate (50 ml).
After 15 minutes, the solvent was removed, 50 ml of toluene was added and the solvent was evaporated again to obtain a phosphonium salt (1.3 g), which was dissolved in 50 ml of tetrahydrofuran and then treated with 4 equivalents of tetrabutylammonium fluoride ( TWAG).
After 1 hour, the mixture was evaporated, dissolved in ethyl acetate.
(50 ml) and washed with a saturated aqueous solution of sodium hydrogencarbonate (3 × 25 ml) and water (25 ml).
The organic phase is separated, dried with anhydrous sodium sulphate and evaporated in vacuo. The oily residue is chromatographed on silica gel (cyclohexane-ethyl acetate) to obtain the title compound, 0.75 g (yield 90%) as a foam.
Step C. 1 Tara-nitrobenzyl (5K) - -2-hydroxymethyl-6 (8) (K) -paranitro-benzyloxycarbonyloxyethyl-D-2-penem-3-carboxylate
OC02PNB
Jn o
Rrz
COORMS
ABOUT
C02PNB
OC02PN
Tn,
 rm
COORMS
thirty
five
0
five

five
A solution of 4 (K) -oxiacetylthio-3 (S) - - {1 (R) -para-nitrobenzyloxycarbonyl oxystilJ-1- (1-para-nitrobenzyloxycarbonyl-1-triphenylphosphanilidene-methyl) -azetidine-2-orone (0) , 6 g) in toluene (200 ml), together with a catalytic amount of hydroquinone, are refluxed for 2 hours. The solution thus obtained is then evaporated in vacuo, and the residue is purified by chromium on a column filled with silica gel, using 8 an eluent mixture consisting of toluene and ethyl acetate gives the title product 0.42 g (yield 79%).
UV spectrum, max, alcohol alcohol: 260 nm (E 319 named (8400).
IR spectrum, l) max, 3600-3.200, 1790, 1745, 1710, 1605, 1580, see
Nuclear Magnetic Resonance Spectrum (CDCl1): 1.51 (3H, d, Hz), 3.99 (1H, dd, I 2.0, 7.5 Hz), 4.69 (2H, broad singlet), 5.15 ( 1H, tn), 5.23 and 5.46 (2H, cent-pbi, ABq, I 14 Hz), 5.26 (2H, s), (1H. D, Hz), 7.51 (2H, d .
 (95% sour - 19100),
(CHClj):
I
Hz), 7.61 (2H, d, l 8 Hz), 8.50 (4H, d, I 8 Hz).
Stage N. Sodium (5K) -2-hydroxymethyl-5 (5) (K) -oxyethyl-2-penem-3-carboxylate
HE
Ln s
„G - KG-Chog
COOPNB
To a solution containing 54 mg of para-nitrobenzyl (5K) -2-hydroxymethyl-6 (3) (R) -para-nitrobenzyloxycarbonyl-hydroxyethyl -2-penem-3-carboxylate, in a mixture with ethyl acetate and water containing 6 mg NaHCOa, 40 mg 5% Pd / C (palladium on carbon) are added. The resulting mixture is hydrogenated at atmospheric pressure for 1 hour. Then another portion of 5% Pd / C (20 mg) is added and stirred for 30 minutes. The resulting mixture is filtered, the aqueous phase is separated and washed with ethyl acetate. After evaporation of the aqueous phase, the residue was cleaned on a reversed phase column, eluted with water. The result is 12 mg (yield 46%) of the title compound as an amorphous solid.
UV spectrum, max. (95% ethyl alcohol): 263 nm, 304 of them.
And p m ime 2. Steps A-G are carried out in accordance with steps A-G of Example 1.
Stage N. Para-nitrobenzyl (5K) - -2-acetoxymethyl-6 (S) (R) -para-nit robenyloxycarbonyloxyethyl -2-pemen-3-carboxylate
OC02PNB
Ng
OSOGR IN

C

A solution of pa.ra-nitrobenzyl (5K) -2-oxymethyl-6 (5) -11 (K) -pA, ra-nitrobene
five
0
five
0
P
five
Zyloxycarbonyloxy-2-penem-3-carboxylate (350 mg, 0.58 mmol) in dry CHClS (5 ml) is sequentially treated with pyridine (140 mg) and acetic anhydride (80 mg) and then stirred at room temperature for 6 The mixture was washed with a solution of sodium hydrogencarbonate (3 x 5 ml) and then with water. The anhydrous organic phase is evaporated and the resulting oily residue is chromatographed on silica gel, elution is carried out with a mixture of cyclohexane and ethyl acetate, to give the title product in an amount of 200 mg (yield 52%).
UV spectrum, D max. (95% ethyl alcohol): 265, 321 nm.
IR spectrum (CHC1 g) l) max .: 1795, 1750, 1515, 1610, 1585 cm-.
Nuclear Magnetic Resonance Spectrum (CDCl1): 1.50 (3H, d, Hz), 2.11 (3N, s) 4.01 (1H, dd, I 1.8, 7.5 Hz), 5.11 and 5, 50 (2H, centers ABq, I 14 Hz); 5.15 (1H, t), 5.24 and 5.38 (2H, centers ABq, I 12 Hz), 5.28 (2H, s), 5.70 (1H, d, I 18 Hz), 7 , 55 (2H, d, I 8 Hz), 7.64 (2H, d, I 8 Hz), 8.22 (4H, d, I 8 Hz).
Stage I. Sodium (5K) -2-acetoxy-methyl-6 (8) (K) -oxystil 2-penem-3-carboxylate.
| N. with

oJ-NOSPCH COOPNB
HE
H - SOOCH: n -N- juice
about
to a solution containing 200 mg of para-nitrobenzyl (5K) -2-acetoxymethyl-6 (S) (R) -para-nitrobenzyloxycarbonyl oxyethylJ 2-penem-3-carboxylate in a mixture consisting of ethyl acetate and tata and water containing NaHCO-j (26 mg) was added 5% Pd / C (200 mg) and the mixture thus obtained was subjected to hydrogenation at atmospheric pressure for 1 h. Then another portion of 5% Pd / C was added.
(100 mg) until complete absorption of Hj. The resulting mixture is filtered, the aqueous phase is separated and washed with ethyl acetate. The organic phase is separated and the aqueous phase is evaporated in vacuo. The residue obtained is purified on a column with a reversible phase, and elution is carried out with water. Evaporation of the aqueous solution affords 60 mg of the product, (57% yield), indicated in the title, as an amorphous solid.
UV spectrum, max. (85% ethyl alcohol): 263 (t 4630), 305 (E 5500)
NMR spectrum cf (pmm)): 1.31 (ZN, d, I 6.5 Hz), 2.19 (ZN, s), 3.92 (1H, dd, I 1.5, 7.0 Hz) , 4.21 (1H, t), 5.10 and 5.44 (2H, centers ABq, I 14 Hz), 5.67 (1H, d, I 1.5 Hz)
(0 /) +116.9, with 0.1, 95% ethyl alcohol).
Calculated,%: C 40.37, H 4.31, N 4.28.
 jNOjSNwH O.
Found,%: C 40.41, H 4.26, N 4.29.
PRI me R 3. Stadi A.
4 (R) -T-butyldimethylsilyloxyacetylthio-3 (S) -I1 (R) -para-nitrobenzyloxycarbonyloxyethyl -1- (1-para- -nitrobenzyloxycarbonyl-1-hydroxymethyl, tely) -azetidin-2-one
OC02PNB
 Y QTBDHS
OCOzP NB
Ih s ..
 X OTBDPS
COiPNB
OT6DW5G kg 0
  OH
0.34 g of 4 (R) -tert-butyl-dimethylsilyl-hydroxy-acetylthio-3 (S) -1 (H) -para-nitrobenzyloxycarbonyloxyethyl-3-azetidin-2-one and 0.34 g of para-nitrobenzylglyoxylate in 10 ml of benzene is distilled at a temperature of reflux for 2 hours. After evaporation of the solvent, the residue is purified by chromatography on a column filled with silica gel, elution is carried out with a mixture consisting of cyclohexane and ethyl acetate in a ratio of 3: 2. The result is 0.27 g (yield 56%) of the title compound.
Nuclear Magnetic Resonance Spectrum (CDCl1), S (ppm): 0.13 (s, 6H, Si (CHj) ,, 0.95 (s.9H, 51C (CH3) s, 1.47 (d, I 6.5 Hz, ZN, CHjCH), 3.52 (m, IH, H-6). 4.27 (s, 2H,). 4.0-4.6 (t, 2H, CHON, SNON) 5.25 ( s, 4H, two CH, Ph), 5.1-5.6 (m, 2H, CHCHj, H-5), 7.3-8.3 (m, 8H, two Ph - N0).
Step B. 4 (I) -T-butyldimethylsilyloxyacetylthio-3 (S) (R) -para-β-nitrobenzyloxycarbonyloxyethyl} - -1- (1-para-nitrobenzyloxycarbonyl-1-β-chloromethyl) -acetidin-2-one
OSOGR IN
1 hour 1 OTBDMS

CO2PNB
-.- brV
about y-ci
C02PNB
A solution of 0.27 g4 (R) -tert-butyldimethylsilyloxyacetylthio-3 (S) - (R) -nara-nitrobenzyloxycarbonyloxyethyl} -1- - (1-para-nitrobenzyloxycarbonyl-1-oxymethyl) -azetidine-2 - It is cooled in 3 ml of tetrahydrofuran which is not solid. Next, 0.045 ml of pyridine and 0.03 ml of thionyl chloride are added. After 10 minutes, the mixture was filtered. By evaporation of the solvent, 0.3 g (yield 93%) of the title compound is obtained, which is used as it is in the next step.
Step C. 4 (K) -t-Butyldimethylsilyloxyacetylthio-3 (S) (R) -napa- -Nitrobenzyloxycarbonyloxyistil -1 - - (1-para-nitrobenzyloxycarbonyl: -1- -triphenylphosphoranylidenomethyl) -azeth- DIN-2- HE
OCOzPVB
- Chr-Y OTBDMS 0 -YPPhj COjPNB
0.3 g 4 (K) -tr et-butyldimethylsilyl oxacetylthio-3 (5) (H) -para-nitrobenzyloxycarbonyloxyethyl -1- (1-para-nitrobenzyloxycarbonyl-1-chloromethyl) -azetidine-2 -one and 0.45 g of triphenylphosphine are dissolved in 5 ml of dichloromethane and 2-3 g of silica gel is added. After evaporation of the solvent, the silica gel containing the compound is dried, held at room temperature for 12 hours and then washed with cyclohexane to remove excess triphenylphosphine. The product adsorbed by silica gel is chromatographed on silica gel, using a mixture consisting of cyclohexane and ethyl acetate in a ratio of 3: 2 as eluent. The result is 0.26 g (yield 78% of the title compound.
Nuclear Magnetic Resonance Spectrum (CDCl1), (f (ppm): 0.08, 0.15 (two s, 6H, .81 (CH, g), 0.89, 0.93 (two s, 9H, SiC (CH5 ) 3, 1.35 (d, I 6.5 Hz, 3N, CH3 SN), 4.1–4.2 (ha, 2H, CHjOSi), 4.6–5.0 (m, 1H, CHCH3) , 5.20 (broad singlet, - 4H, two CHj-Ph - N0j), 7.56 (broad singlet, 15 H, P (Ph),), 7.6-8.4 (m, 8H, two Ph - NOr).
Stage D. 4 (K) -Oxyacetylthio-3 (8) - 1 (K) -para-nitrobenzyloxycarbonyloxyethylZ-1- (1-para-nitrobenzyloxycarbonyl-1-triphenylphosphoranylidene-methyl) -azetidin-2-one
OC02PNB
-Tg
OTBDMS
rrh
C02PNB
horn
 T
 ABOUT
YPPb3
C02PNB
ABOUT
A solution containing 0.26 g of 4 (R) - -tert-butyldimethylsilyloxyacetyl-thio-3 (5) -1 (E) -para-nitrobenzyloxycarbonyloxyethyl -1- (1-para-nitro-benzyloxycarbonyl-1-triphenylphosphorus- anilidene) -azetidin-2-one and 0.07 ml of acetic acid in 2. ml of anhydrous tetrahydrofuragg, treated with a solution containing 0.18 g
tetrabutylammine fluoride in 2 ml of tetrahydro4 uranium. After stirring the resulting mixture at room temperature for 1.h, it is diluted with ethyl acetate, washed with water, saturated NaHCO3 and again with water.
After drying and evaporation of the solvent, the obtained residue was purified by chromatography on a column of silica gel, eluting with a mixture consisting of cyclohexane and ethyl acetate in a ratio of 1: 3. The result is a connection specified in the header, in an amount of 0.13 g, yield 57%. . .
NMR (CBC1) spectrum, f (ppm): 1.37 (d, I 6.5 Hz, 3N, SNSN), 4.2 (hectare, 2H,), 4.9 (t, 1H, CH3CN), 5 , 25 (ha, 5H ,, two, H-5), 7.55 (s, 15H, P (Ph) j), 7.6-8.4 (m, 8H, two Ph, NO,).
Stage E. Para-nitrobenzyl (5U- -2-hydroxymethyl-6 (S) (R) -para-nitrobenzyloxycarbonyloxyethyl J-2-penem-3-carboxylate
gcozPNBosogRmv
S. Gn
I I about PPH3 C02PNB
ABOUT
ABOUT
-S CH20H C02PNB

0
five
five
A solution of 0.13 g of 4 (K) -oxy-acetyl-thio-3 (5) -1 (K) -para-nitrobenzyloxycarbonyloxyethyl -1- (1-para-nitro-benzyloxycarbonyl-1-triphenylphosphoric anilideneethyl) -azetidine- 2-she in 10 ml of xylene is refluxed under nitrogen for 1 hour. Evaporation of the solvent and purification using preparative chromatography on silica gel films gives 50 mg (yield 57%) of the title compound.
(o;) o 266 (c 1.3, CHCl j).
Nuclear Magnetic Resonance Spectrum (CDCla), t (ppm): 1.51 (d, I 6.5 Hz, 3N, SNZON), 3.55 (broad singlet, 1H, OH), 3.97 (dd, I 2.0 , 8.0 Hz, GN, H-6), 4.68 (s, 2H, SNgON), 5.19, (dq I 6.5, 8, O Hz 1H, CHCHNz), 5.25-5, 45 (t, 4H, two QUjPh) 5.65 (d, I 2.0 Hz, 1H, H-5), 7.4-8.5 (ha, 8H, two Ph N0 j).
Mass Spectrum (FD) m / l 559.
UV spectrum A max. (): 269 nm (g 17,000), 323 (6800).
IR spectrum (,) (cm-): 1795, 1755, 1710.
Stage F. Para-nitrobenzyl (5R) - -2- (N-trix. Poro-ethyl-ap6-amino-oxo-methyl) -6 (S) (K) -para-nitrobenzyl-oxycarbonyloxy-istil-2-penem-3-carboxylate
OCOaPNB
J-JL -YCH20H oJ-N- (
 C02PNB
OCOzPNB H S
ABOUT
to: OSSHNOSNz ".02PNB
To a solution containing 50 mg of para-nitrobenzyl (5R) -2-oxymethyl-6 (S) - - 1 (K) -para-nitrobenzyloxycarbonyl oxyethylJ -2-penem-3-carboxyl.at in 1 ml of purified acetone, when cooled to 0 ° C, a solution of 0.06 ml of trichloroacetyl isocyanate in 1 ml of purified acetone is added dropwise. After 20 minutes, the solvent is evaporated, and 67 mg (yield 100%) of the title compound is obtained.
Nuclear Magnetic Resonance Spectrum (CDCl1) tf (ppm): 1.50 (d, I Hz, 3N, CHjCH), 4.00 (dd, I 2.0, 8.0 Hz, 1H, H-6), 5.1 - 5.9 (m, 8H, H-5, OTO, two, CH, CCA), 7.5-8.4 (t, 8H, two Ph N0z 8.90 (broad singlet, 1H, NH).
Step G. Para-nitrobenzyl (5R) - -2-carbamoyloxymethyl-6- (5) - 1 ((R) - -para-nitrobenzyloxycarbonyloxyethyl 3-2-penem-3-carboxylate

OCOMHCOCCls,
ocoNHCOoce
OCOzPl B
3

100 mg of para-nitrobenzyl (5R) -2- (N-: -trichloroacetylcarbamoyloxymethyl) -6 (S) (R) -pap-nitro-benzyl-2-p-bonyloxyethyl -2-penem-3-carboxylate is dissolved in 4 ml of methanol. Then silica gel (40-63 ppm) is added,
The resulting mixture was stirred for 3 hours at room temperature, filtered and then washed with acetone. After evaporation of the solvent from the filtrate, the residue was purified by preparative chromatography in silica thin films on cyclohexane and ethyl acetate as follows: 3: 7, resulting in 33 mg, (yield 61%) of the title compound.
(about)
20
 +
50 (with 2.4, acetone).
Nuclear Magnetic Resonance Spectrum (CDCl1) f (ppm); 1.48 (d, I 6.5 Hz, 311, ShzSN), 3.95 (dd, I 2.0, 8.0 Hz, 1H, H-6) 4 , 85 (broad singlet, 2H, NH2), 5.1-5.5 (ha, 7H, CHCHj two CHjPh,), 3.64 (d, I 2.0 Hz, 1H, H-5), 7, 4-8,5 (m, 8H, two, (Pb N0).
IR spectrum (KBG g (cm- 0: 1795, 1750, 1710.
Stage N. Sodium (5R) -2-Kap6aMo- .yloxymethyl-6- (5) - 1 (R) -oxxy-J2-, -penem-3-carboxylate
OC02PNB
 S
mc
 Oconh
30 mg of para-nitrobenzyl (5R) - -carbamoyloxymethyl-6 (5) -G1 (R) -napa-nitrobenzyloxycarbonyloxyethyl -2- -penem-3-carboxylate is dissolved in 3 ml of ethyl acetate. Then add 2 ml of water, 4 , 2 mg of NaHCO, and 45 mg of 5% palladium on carbon. The resulting mixture is subjected to hydrogenation at room temperature for two hours. After filtration through diatomaceous earth, the aqueous phase is washed with a small amount of cold ethyl acetate, filtered through a Waters Sep-Pak C ,, filter cartridge, and lyophilized. The residue was purified by reversed phase chromatography on a Waters Ber-Pak C, g filtration cartridge, eluting with water. As a result, 8 mg (yield 52%) of the compound indicated in the title is obtained.
UV spectrum, A max, (H, 0): 259 nm (C 3600), 308 (5400),
Nuclear Magnetic Resonance Spectrum (DiO), f (ppm): 1.31 (d, I 6.5 Hz, 3N, CH, CH), 3.91 (dd, I 1.5, 6.0 Hz, 1H, H -6, 4.25 (t, 1H, CHON), 5.02, 5.36 (two o /., 2H, CH20CO), 5.66 (d, .1 1.5 Hz, 1H, H-5 );
(o () d + 143 (s, 0.96 HiO).

权利要求:
Claims (1)
[1]
Invention Formula
Method for producing optically active penems of general formula (I)
 Gyr
0 1J-CSL
de R, - 1-hydroxy-C-C4-alkyl}
15
20
R.
R
- hydrogen, acetyl or carbamoyl group, not necessarily protected by trichloro-25 acetyl group
-hydrogen or p-nitrobenzyl, or in the case when RJ is hydrogen, their salts with alkali metals by converting a compound of the general, formula (II)
S CHZ
iv-gchsn
O n-tx
 COORit
where R is indicated more; R C1 C4-alkyl,
in 3,4-disubstituted 1- (1-C1-C4-alkoxycarbonyl-2-methyl-2-propenyl) - azetidin-2-one in the first stage and its isomerization to 3,4-disubstituted35
40
where R and R are indicated above, resulting from it and the merization of 3,4-disubstituted 1- (1 -C4-alkoxycarbonyl-2-methyl-1-penyl) -azetidin-2-one of the general form (V)
RI
ABOUT
OOSNz
-N,
where R, H R indicated above, treated with potassium permanganate, if desired, in the presence of a period
Ny l-d-C-C alkoxycarbonyl 2 med sodium, which forms the compound til-1-propenyl) -azetidin-2-one under the general formula (VI)
by the action of triethylamine in dichloromethane medium at 5 ° C in the second stage, using the successive stages of the interaction of 3,4-disubstituted azetidinone-2 with a compound of the general formula (III)
CHO COORj,
where Rj is as indicated above, in benzene at 70-100 ° C, the chlorination of the resulting 3,4-disubstituted 1- (1-Rj-hydroxycarbonyl-1-hydroxymethyl) -azetidinone-2 with thionyl chloride in the presence of pyridine at (-5) - ( 0) and reacting the resulting 3,4-disubstituted 1-1-K hydroxycarbonyl--1-chloromethyl) -azetidin-2-one with triphenylphosphine PRILO B C and using cyclization 3,4-disubstituted 1- ( 1-Cs-oxycarbonyl-1-triphenylphosphoranylidenemethyl) -azetidin-2-one by heating in an aromatic hydrocarbon medium and isolating the target product, characterized in that, in order to increase the yield and
expanding the range of desired products, the compound of formula (II) is converted into 3,4-disubstituted with acetic acid and trimethyl phosphite in toluene
1- (1-С, -C-alkoxycarbonyl-2-methyl
-2-Propenyl) -azetidin-2-one of the general formula (IV)
R
o-pine
read about b
and COOR t
where R and R are indicated above, resulting from isomerization, 3,4-disubstituted 1- (1-Ci-C4-alkoxycarbonyl-2-methyl-1-propyl) -azetidin-2-one of general formula (V)
RI
ABOUT
OOSNz
-N,
where R, H R indicated above, treated with potassium permanganate, if desired, in the presence of periodate
sodium formed compound of general formula (VI)
RlN -.- r-OCOCHj oJ-N-H
where RI is indicated, the above is subjected to interaction with the compound of the general (}) formula (VII)
HSCOCHjORy
where Rj is t-butyldiphenylsilyl
or t-butyldimethylsilyl.
the resulting 3,4-disubstituted zion-2 of general formula VIII
iY- / V- OR5
H
where R, and R,
above indicated
neither
subjected to successive stage of interaction with the compound of the formula (III) chlorination and interaction with triphenylphosphine with the sequential formation of respectively the general formulas (IX, X and X1)
T / v
SOOKz S
R
0
rV "
Vci
SOORs
-.
R r r r 0 5
About RSSBNa
SOOYZ
Editor M.Nedoluzhenko
Comptroller Z. Lapytova Tehred M. Khodanych
Order 1588/58
Circulation 370
VNIIPI USSR State Committee
for inventions and discoveries 113035, Moscow, Zh-35, Raushsk nab., 4/5
where r ,,
Rj and R,
listed above.
in the compound of the general formula (XI), the protecting oxy group is removed, and the resulting 3,4-disubstituted l-d-Rj-oKCHKap-bonyl-1-triphenylphosphoranyl isidene-metip-α-azetidinone-2 with the general formula XII is subjected to cyclization
 ABOUT
ur (sbh5) s
COOR.
where R, and RJ are indicated above, in an environment of toluene or xylene as an organic solvent at 80-150 ° C with the separation of the target product, where R is hydrogen, or its ob-; Work with acetic anhydride at room temperature in methylene chloride in the presence of pyridine or trichloroacetyl isocyanate in acetone and, if necessary, remove the protective group by treating with silica gel in methanol or hydrogen in ethyl acetate in the presence of 5% palladium on carbon and, if necessary, the target product, where Rii is hydrogen, is isolated in the form of its salt with an alkali metal by treatment with a base.
Proofreader O. Kravtsov
Subscription

类似技术:

---

公开号 | 公开日 | 专利标题

---

Ernest et al.1978|The penems, a new class of. beta.-lactam antibiotics: 6-acylaminopenem-3-carboxylic acids

---

Knapp et al.1988|Synthesis and reactions of iodo lactams

---

JP4121215B2|2008-07-23|Sulfostin analog, and method for producing sulfostine and its analog

---

SU1389680A3|1988-04-15|Method of producing optically-active penems or salts thereof with alkali metals

---

EP0023097B1|1984-08-01|De-arylmethylation of n-mono- or n-diarylmethyl-beta-lactams; novel azetizinones having anti-bacterial activity

---

US4443373A|1984-04-17|Process for the production of antibiotic penems

---

US4882429A|1989-11-21|Stereospecific preparation of |-3-|-4-benzoyloxy-azeridinones from L-|-theonine

---

EP0060416B1|1986-08-20|New beta-lactam acetic acid derivatives, the process for preparing them, and their use as intermediates for 1-azabicyclo|hept-2-ene antibiotics

---

US4210661A|1980-07-01|Synthetic β-lactam compounds, a process for their preparation and compositions containing them

---

US4427586A|1984-01-24|2-Oxoazetidine derivatives and production thereof

---

EP0018546B1|1983-09-28|Process for the production of phenylglycyl chloride hydrochlorides

---

Ernest1977|Penicillin-derived diazoketones: Copper | catalyzed decomposition in aprotic media

---

Gallucci et al.1989|Preparation of aminosaccharides using ester-imine condensations: syntheses of methyl N-benzoylacosaminide and methyl N-[oxo | acetyl) daunosaminide from |-ethyl 3-hydroxybutyrate

---

HAYASHI et al.1981|2-| penem-3-carboxylic acids. V. Synthesis and antibacterial activities of" 1-thiathienamycin" and related compounds

---

US7906495B2|2011-03-15|Monohalogenovinyl vitamin D derivative compounds

---

US5106996A|1992-04-21|Process for the preparation of podophyllotoxin

---

US5081238A|1992-01-14|βmethyl azetidinone derivatives and stereoselective process for preparing the same

---

GB2138808A|1984-10-31|B-amino acid derivatives and their preparation

---

US4767853A|1988-08-30|Synthesis of 1-|-methyl-3-|-4-beta-naphthoxythiocarbonylthio-2-azetidinones and hydroxy protected analogs thereof

---

US4238622A|1980-12-09|D,L-2-Amino-4-|-trans-but-3-enoic acid derivatives

---

US5118831A|1992-06-02|Amino acid derivatives, their production and use in preparing carbapenem and carbapenam compounds

---

EP0209886B1|1990-03-21|Beta-n-substituted aminothiol ester and process for preparing the same

---

US4663451A|1987-05-05|Process for the synthesis of penems and penams

---

US5053502A|1991-10-01|Anhydro penicillin derivatives

---

US4948885A|1990-08-14|Synthesis of azetidinones

同族专利:

---

公开号 | 公开日

---

AT379399B|1985-12-27|

---

IL67434A|1986-07-31|

---

JPS58126888A|1983-07-28|

---

JPH045033B2|1992-01-30|

---

HU187807B|1986-02-28|

---

FI824192A0|1982-12-07|

---

IT8224650D0|1982-12-09|

---

ATA443582A|1985-05-15|

---

AU9115682A|1983-06-16|

---

NL8600460A|1986-06-02|

---

ZA829063B|1983-09-28|

---

DE3245270C2|1997-05-15|

---

US4508649A|1985-04-02|

---

BE895322A|1983-06-10|

---

GR77078B|1984-09-06|

---

FR2518098B1|1986-02-21|

---

FR2567888B1|1987-04-17|

---

FI76347C|1988-10-10|

---

SE458684B|1989-04-24|

---

JPH0146516B2|1989-10-09|

---

GB2111496B|1985-05-09|

---

FI76347B|1988-06-30|

---

JPS61178987A|1986-08-11|

---

DK160311B|1991-02-25|

---

CH655504B|1986-04-30|

---

IE822917L|1983-06-11|

---

AU556854B2|1986-11-20|

---

GB2111496A|1983-07-06|

---

DK551182A|1983-06-12|

---

SE8207092D0|1982-12-10|

---

DK160311C|1991-07-29|

---

FR2567888A1|1986-01-24|

---

IE54513B1|1989-11-08|

---

NL8204720A|1983-07-01|

---

SE8207092L|1983-06-12|

---

IT1206106B|1989-04-14|

---

FR2518098A1|1983-06-17|

---

CA1215705A|1986-12-23|

---

DE3245270A1|1983-06-23|

---

IL67434D0|1983-05-15|

---

FI824192L|1983-06-12|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US4348320A|1976-11-19|1982-09-07|Merck & Co., Inc.|Substituted azetidiones|

---

EP0003960B1|1978-02-02|1983-06-29|Ciba-Geigy Ag|6-substituted thia-aza-compounds, their preparation and pharmaceutical compositions containing them|

---

US4331677A|1978-11-24|1982-05-25|Farmitalia Carlo Erba S.P.A.|7-Oxo-4-1-aza-bicyclo-[3,2,0]-heptane derivatives|

---

EP0013067A1|1978-12-22|1980-07-09|Beecham Group Plc|Bicyclic beta-lactam antibacterial agents, their use in pharmaceutical compositions, processes for their preparation and intermediates for use in such processes|

---

GB2037277B|1978-12-22|1983-05-05|Beecham Group Ltd| -lactam antibacterial agents their use in pharmaceutical compositions processes for their preparation and intermediates for use in such processes|

---

GR73623B|1979-02-24|1984-03-26|Erba Farmitalia|

---

US4269771A|1979-04-06|1981-05-26|Farmitalia Carlo Erba|Total synthesis of 7-oxo-4-thia-1-azabicyclo-[3,2,0]-heptane-2-carboxyl derivatives useful as β-lactamase inhibitors and antibacterial agents|

---

JPH0372630B2|1979-04-11|1991-11-19|Sankyo Co|

---

US4482565B1|1980-02-22|1987-11-03|

---

GB2079744A|1980-07-04|1982-01-27|Erba Farmitalia|6-Alkyl-2-functionalized penems|NO831160L|1982-04-08|1983-10-10|Erba Farmitalia|PREPARATION OF SUBSTITUTED PENEM DERIVATIVES|

---

GB8300295D0|1983-01-06|1983-02-09|Erba Farmitalia|Penem esters|

---

GB8321677D0|1983-08-11|1983-09-14|Erba Farmitalia|Preparation of penems|

---

JPS62501556A|1984-07-13|1987-06-25|

---

GB8713515D0|1987-06-10|1987-07-15|Erba Farmitalia|Methoxymethyl compounds|

---

GB8818789D0|1988-08-08|1988-09-07|Erba Carlo Spa|Crystalline-2-carbamoyloxymethyl-6--hydroxyethyl)-2-penem-carboxylic acid & pharmaceutical formulation|

---

DE68920298T2|1988-11-29|1995-07-27|Takasago Perfumery Co Ltd|Process for the preparation of 4-acetoxyazetidinones.|

---

US5204460A|1988-11-29|1993-04-20|Takasago International Corporation|Ruthenium catalyzed process for preparing 4-acetoxyazetidinones|

---

EP0597401A3|1992-11-11|1995-07-26|Takeda Chemical Industries Ltd|Production of penem.|

---

JP4512651B2|2008-06-18|2010-07-28|三井金属鉱業株式会社|Opening and closing device for vehicle opening and closing body|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

GB8137513|1981-12-11|

---